Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Thai Research Breakthrough Published in International Scientific Journal A Milestone of Success
Via Newsfile
Topics Death
Exposures Death Product Safety
Q1 Rundown: DexCom (NASDAQ:DXCM) Vs Other Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers DXCM PODD
Dyne Therapeutics Stock Drops After ‘Surprise’ Pivot In Primary Endpoint For Muscle Drug Trial
Via Stocktwits
Exposures Product Safety
Tickers DYN
Cero Therapeutics Rockets On FDA Orphan Drug Status For Blood Cancer Drug; Retail Bulls Feel Stock 'Still Has A Few Pumps Left'
Via Stocktwits
Exposures Product Safety
Tickers CERO
FDA Introduces Tumor Board-Style Reviews For Faster Drug Decisions
Via Benzinga
Exposures Product Safety
Waymo Expands Robotaxi Services To More Parts Of San Francisco Bay, Silicon Valley, And Los Angeles
Via Stocktwits
Exposures Product Safety
Tickers GOOG GOOGL TSLA
FDA Aims To Reduce Drug Application Review Time With New Voucher Program
Via Stocktwits
Exposures Product Safety
Tickers BAC IHE PJP PPH
Why Is Dyne Therapeutics Stock Trading Lower On Tuesday?
Via Benzinga
Exposures Product Safety
Tickers DYN
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
Tickers INBS
New Tree’s Desugared Juice Revolutionizes Fruit Nutrition: Full Nutritional Value with Zero Sugar and No Guilt
Via Press Release Distribution Service
Topics Economy
Exposures Economy Product Safety
BiomX Stock Could Soar 3000% As This $10M Biotech Cracks The 'Superbug' Code, Wall Street Says
Via News Direct
Exposures Product Safety
Tickers PHGE
Dr. Thomas John Byrne OBGYN Spotlighted for Lifelong Learning and Leadership in Women’s Health
Via Get News
Topics Product Recall
Exposures Legal Product Safety
HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Ocugen (OCGN) Stock Soars On FDA Clearance For Pivotal Stargardt Disease Trial
Via Benzinga
Exposures Product Safety
Tickers OCGN
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
Via Investor Brand Network
Exposures Product Safety
Tickers NRXP
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers ELTP
Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy
Via Benzinga
Topics Death
Exposures Death Product Safety
Tickers RHHBY SRPT
After 19 Explosions And Fire Injuries, Anker Recalls Over 1 Million Power Banks Sold Since 2016 — Is Yours Affected?
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
UroGen Pharma Stock Scores Bullish Price Target Revisions Up To $47 Following FDA Nod For Zusduri
Via Stocktwits
Exposures Product Safety
Tickers GS URGN
Sarepta Pauses DMD Gene Therapy Trial After Second Death; Retail Traders Brush Off Risk
Via Stocktwits
Exposures Product Safety
Tickers SRPT
Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased
Via Stocktwits
Exposures Product Safety
Tickers AKRO GILD LLY PFE
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Reported Q1 2025 Results, Advanced Toward Commercialization Following VALID-ECG Study Success
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Why UroGen Pharma (URGN) Stock Is Skyrocketing This Week
Via Benzinga
Exposures Product Safety
Tickers URGN
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
Via Benzinga
Exposures Product Safety
Tickers MLTX MRK
Merck Gets FDA Approval For Keytruda To Treat A Broader Population Of Head And Neck Cancer Patients: Retail Stays Bullish
Via Stocktwits
Topics Death
Exposures Death Product Safety
Tickers AMZN MRK VOO VTI
Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst
Via Benzinga
Exposures Product Safety
Tickers ISRG MDT
Kaplan Fox Alerts Investors of Unicycive Therapeutics to an Investigation of Possible Securities Law Violations
Via NewMediaWire
Exposures Product Safety
Tickers UNCY
Kaplan Fox Alerts Investors of Unicycive Therapeutics to an Investigation of Possible Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers UNCY
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.